Director, Competitive Intelligence
About The Position
Stoke Therapeutics (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary approach, the company is developing antisense oligonucleotides (ASOs) to selectively restore naturally occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke entered into a strategic collaboration with Biogen in 2025 to develop and commercialize zorevunersen for Dravet syndrome. Under the collaboration, Stoke retains exclusive rights for zorevunersen in the United States, Canada, and Mexico; Biogen receives exclusive rest of world commercialization rights STK-002 is Stoke’s proprietary antisense oligonucleotide (ASO) in clinical development for the treatment of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorder. STK-002 has been granted orphan drug designation by the FDA. A Phase 1 study (OSPREY) of STK-002 in people with ADOA is now underway. The company is also conducting early research in Syngap1, a severe and rare neurodevelopmental disorder, in collaboration with Acadia Pharmaceuticals. Stoke’s initial focus is on diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for the Company’s proprietary approach. The Director, Competitive Intelligence (CI) will be responsible for delivering actionable competitive insights to support strategic decision-making for both zorevunersen and earlier stage pipeline assets. The Director will partner closely with cross-functional teams, including Commercial, Medical, Clinical and Regulatory to inform portfolio and product strategy. This role will report into the Vice President, Corporate Strategy and Chief of Staff.
Requirements
- Bachelor’s degree required; advanced degree (MBA, MPH, PharmD, MS) strongly preferred.
- 10+ years of relevant experience in pharma/biotech or healthcare consulting with a focus on competitive and market intelligence.
- Proven ability to deliver actionable insights across the product lifecycle, from early development through post-launch.
- Demonstrated capability to synthesize complex datasets into clear, executive-ready recommendations that influence strategic decisions.
- Extensive experience collaborating with and advising senior leadership; skilled in leading cross-functional and global initiatives.
Nice To Haves
- Experience in rare disease, neuroscience, or genetic medicine preferred.
Responsibilities
- Lead end-to-end competitive intelligence for zorevunersen and pipeline assets.
- Develop, implement, and scale CI processes, tools, and methodologies.
- Partner with Program Teams and senior leadership to embed CI into brand, portfolio, and corporate strategic planning.
- Translate complex market, clinical, and regulatory signals into clear, actionable recommendations that inform strategic decisions.
- Attend key conferences to monitor competitor activity and emerging trends.
- Analyze diverse data sources to identify trends and business opportunities.
- Serve as the primary interface with external CI vendor, ensuring clarity of objectives and quality of deliverables.
- Own CI budgets, project scopes, and timelines.
Benefits
- Our benefits package includes medical, dental and vision insurance; life, long- and short-term disability insurance; paid parental leave; a 401K plan with company match, unlimited vacation time, tuition assistance and participation in our Employee Stock Purchase Program (ESPP).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Director
